
The £10M Lie: Why the British Heart Foundation's Data Push is a Trojan Horse for Big Pharma
The BHF's massive data science investment isn't just about saving hearts; it's about who owns the future of **cardiovascular health data**.

The BHF's massive data science investment isn't just about saving hearts; it's about who owns the future of **cardiovascular health data**.

The US is rewriting its **dietary guidelines**. Unpacking the political theater behind the 'Make America Healthy Again' movement and who stands to gain from this **nutrition** shift.

Omaha FBI warns about AI exploitation, but the real threat isn't the tech—it's regulatory capture and data centralization in the age of advanced cybercrime.

The new Luxembourg science centre promises public engagement, but it's really a sophisticated talent pipeline for the EU's deep-tech future.

The British Heart Foundation's £10m data science push is great PR, but the real story in **cardiovascular research** funding is data ownership and privatization.

The slow start of the latest Black health study reveals a systemic failure. We analyze the real agenda behind these reports.

Aurobindo's CuraTeQ just snagged Health Canada approval for Dyrupeg, but this isn't just a regulatory win; it's a calculated strike in the escalating global **biosimilar market** battle.

The real shockwave from OpenAI targeting healthcare isn't better diagnoses; it's the massive centralization of patient and provider data.

Behind the curtain of glossy book reviews lies a dangerous trend stifling true science fiction and fantasy.

The recent basketball upset isn't just sports news; it's a stark warning about the widening gap in access to elite **technology** resources and **high school sports**.
The rise of health modeling experts like Wirichada Pan Ngum signals a power shift. But who controls the algorithms shaping our future health policy?

The push for new public health skills ignores the real power shift: from epidemiology to algorithmic control.